VivoSeq
Other

Neck Pain

17

Pipeline Programs

15

Active Trials

10

Companies Involved

Neck pain is an emerging landscape with 17 programs across 10 companies. The most active players are Astellas, Averitas Pharma, Inc., Roche. 5 therapies are approved with 1 more in late-stage development.

Pipeline Metrics

Competitive Density

48/100

Pipeline Velocity

42/100

Mech. Concentration

10/100

Completion Rate

94/100

Attrition Rate

3/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

36

clinical trials

Completed17 · 47%
Recruiting7 · 19%
Not yet recruiting5 · 14%
Unknown status3 · 8%
Active, not recruiting2 · 6%
Withdrawn1 · 3%
Other1 · 3%

Trial Activity

36 trials

Phrenic Nerve Infiltration in Neck Pain
Recruiting·UUniversity of Seville·Phase 4·NCT05605639·60 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)